Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.63 USD | +3.35% | +5.33% | +3.20% |
05-06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
05-02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.20% | 12.14B | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
-2.67% | 12.08B | |
+30.23% | 11.98B | |
+20.99% | 11.58B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Transcript : Bio-Techne Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09